Clinical Trials Directory

Trials / Completed

CompletedNCT02046668

The Effect of Spironolactone on Pain in Older People With Osteoarthritis

A Randomised Placebo Controlled Trial. The Effect of Spironolactone on Pain in Older People With Osteoarthritis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
86 (actual)
Sponsor
University of Dundee · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

This pilot study will obtain preliminary evidence on which to base sample size calculations for a future trial of whether spironolactone (an aldosterone blocker) reduces knee pain in older people with symptomatic OA knee when given in addition to usual analgesia. Aldosterone is known to be pro-inflammatory, and spironolactone suppresses cytokine production in chronic arthritis. This application builds on previous work by the applicants showing that spironolactone significantly improved quality of life (particularly pain) in frail older people. The investigators will recruit 86 people (aged 70 years or over) with well-defined OA knee to 25mg spironolactone daily or to matching placebo for 12 weeks. The primary outcome is the between group difference in change in WOMAC pain sub-score at 12 weeks. Secondary outcomes are the WOMAC stiffness and physical function subscales and health related quality of life (EQ-5D). Morning cortisol levels will be measured to assess the effect of mineralocorticoid receptor blockade on glucocorticoid levels, which may mediate the anti-inflammatory effect of spironolactone; and urinary CTX-II, and serum matrix metalloproteinase-3 (MMP-3) will be measured as biomarkers as both are sensitive to the effects of pharmacological interventions for osteoarthritis.

Conditions

Interventions

TypeNameDescription
DRUGspironolactonespironolactone 25mg daily for 12 weeks

Timeline

Start date
2013-11-01
Primary completion
2015-03-01
Completion
2015-05-01
First posted
2014-01-28
Last updated
2019-10-14

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02046668. Inclusion in this directory is not an endorsement.